BIOMERICA INC (BMRA) Stock Fundamental Analysis

NASDAQ:BMRA • US09061H4065

2.08 USD
+0.03 (+1.46%)
Last: Feb 27, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, BMRA scores 2 out of 10 in our fundamental rating. BMRA was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While BMRA seems to be doing ok healthwise, there are quite some concerns on its profitability. BMRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • BMRA had negative earnings in the past year.
  • BMRA had a negative operating cash flow in the past year.
  • In the past 5 years BMRA always reported negative net income.
  • BMRA had a negative operating cash flow in each of the past 5 years.
BMRA Yearly Net Income VS EBIT VS OCF VS FCFBMRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • BMRA's Return On Assets of -66.71% is on the low side compared to the rest of the industry. BMRA is outperformed by 71.35% of its industry peers.
  • The Return On Equity of BMRA (-90.76%) is worse than 60.54% of its industry peers.
Industry RankSector Rank
ROA -66.71%
ROE -90.76%
ROIC N/A
ROA(3y)-65.89%
ROA(5y)-60.11%
ROE(3y)-90.92%
ROE(5y)-81.57%
ROIC(3y)N/A
ROIC(5y)N/A
BMRA Yearly ROA, ROE, ROICBMRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of BMRA (5.61%) is worse than 82.16% of its industry peers.
  • In the last couple of years the Gross Margin of BMRA has declined.
  • BMRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.95%
GM growth 5Y-18.46%
BMRA Yearly Profit, Operating, Gross MarginsBMRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • BMRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BMRA has more shares outstanding
  • Compared to 5 years ago, BMRA has more shares outstanding
  • BMRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMRA Yearly Shares OutstandingBMRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
BMRA Yearly Total Debt VS Total AssetsBMRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -11.74, we must say that BMRA is in the distress zone and has some risk of bankruptcy.
  • BMRA's Altman-Z score of -11.74 is on the low side compared to the rest of the industry. BMRA is outperformed by 79.46% of its industry peers.
  • There is no outstanding debt for BMRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.74
ROIC/WACCN/A
WACC9.93%
BMRA Yearly LT Debt VS Equity VS FCFBMRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • BMRA has a Current Ratio of 3.25. This indicates that BMRA is financially healthy and has no problem in meeting its short term obligations.
  • BMRA has a Current ratio (3.25) which is in line with its industry peers.
  • A Quick Ratio of 2.29 indicates that BMRA has no problem at all paying its short term obligations.
  • BMRA has a Quick ratio of 2.29. This is comparable to the rest of the industry: BMRA outperforms 58.92% of its industry peers.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 2.29
BMRA Yearly Current Assets VS Current LiabilitesBMRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.20% over the past year.
  • BMRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.05%.
  • Measured over the past years, BMRA shows a decrease in Revenue. The Revenue has been decreasing by -4.51% on average per year.
EPS 1Y (TTM)38.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.25%
Revenue 1Y (TTM)-20.05%
Revenue growth 3Y-34.47%
Revenue growth 5Y-4.51%
Sales Q2Q%-26.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMRA Yearly Revenue VS EstimatesBMRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
BMRA Yearly EPS VS EstimatesBMRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 -1 -2 -3 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • BMRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMRA Price Earnings VS Forward Price EarningsBMRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMRA Per share dataBMRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BMRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIOMERICA INC

NASDAQ:BMRA (2/27/2026, 8:00:02 PM)

2.08

+0.03 (+1.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12
Earnings (Next)04-13
Inst Owners3.01%
Inst Owner Change0.74%
Ins Owners8.81%
Ins Owner Change0%
Market Cap6.28M
Revenue(TTM)4.46M
Net Income(TTM)-4.03M
Analysts85.71
Price TargetN/A
Short Float %2.92%
Short Ratio1.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.41
P/FCF N/A
P/OCF N/A
P/B 1.42
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-1.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.98
OCFYN/A
SpS1.48
BVpS1.47
TBVpS1.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.71%
ROE -90.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.61%
FCFM N/A
ROA(3y)-65.89%
ROA(5y)-60.11%
ROE(3y)-90.92%
ROE(5y)-81.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.95%
GM growth 5Y-18.46%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.76%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 2.29
Altman-Z -11.74
F-Score4
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)94.83%
Cap/Depr(5y)109.76%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.05%
Revenue growth 3Y-34.47%
Revenue growth 5Y-4.51%
Sales Q2Q%-26.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.94%
OCF growth 3YN/A
OCF growth 5YN/A

BIOMERICA INC / BMRA FAQ

Can you provide the ChartMill fundamental rating for BIOMERICA INC?

ChartMill assigns a fundamental rating of 2 / 10 to BMRA.


What is the valuation status for BMRA stock?

ChartMill assigns a valuation rating of 0 / 10 to BIOMERICA INC (BMRA). This can be considered as Overvalued.


Can you provide the profitability details for BIOMERICA INC?

BIOMERICA INC (BMRA) has a profitability rating of 0 / 10.


Can you provide the financial health for BMRA stock?

The financial health rating of BIOMERICA INC (BMRA) is 6 / 10.